Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Clinical trial NCT05378945 · COMPLETED

Trial details

NCT number: NCT05378945
Sponsor: Corxel Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2022-07-22
Primary completion: 2023-04-04
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.